CDMO Avid Bioservices Inc

Avid Bioservices Inc is engaged in development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture.

$19.28  +1.02 (5.59%)
As of 09/28/2022 15:59:58 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  62,167,454
Average volume:  688,000
Market cap:   $1,104,093,983
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BFMZ4W7
Valuation   (See tab for details)
PE ratio:   106.31
PB ratio:   19.57
PS ratio:   9.52
Return on equity:   24.86%
Net income %:   12.13%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy